Frameworks for pharmaceutical innovation in developing countries - The case of Indian pharma

Technology Analysis and Strategic Management

Volumn 19, Issue 5, 2007, Pages 697-708

  Chataway, Joanna ^a   Tait, Joyce ^a   Wield, David ^a  

^a OPEN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPING WORLD; DRUG DEVELOPMENT; INNOVATION; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT;

ASIA; EURASIA; INDIA; SOUTH ASIA;

EID: 34548569339     PISSN: 09537325     EISSN: 14653990     Source Type: Journal    
DOI: 10.1080/09537320701521465     Document Type: Article

References (30)

1. Including the articles by D. Kale & S. Little, From imitation to innovation: The evolution of R&D capabilities and learning processes in the Indian pharmaceutical industry, Technology Analysis and Strategic Management, 19(5), 2007
2. and K. Chaturvedi, J. Chataway & D.Wield, Policy, markets and knowledge: strategic synergies of Indian pharmaceutical firms,Technology Analysis and Strategic Management, 19(5), 2007.
3. H. Thorsteinsdóttir, The role of the health system in health biotechnology in developing countries, Technology Analysis and Strategic Management, 19(5), 2007
4. H. Thorsteinsdóttir, T.W. Saenz, U. Quach, A. S. Daar & P. A. Singer, Cuba-innovation through synergy,Nature Biotechnology, 22, 2004, DC19-24.
5. L. Kim, Imitation to Innovation: The Dynamics of Korea's Technological Learning (Cambridge, MA, Harvard Business School Press, 1997)
6. M. Hobday, Firm-level innovation models: Perspectives on research in developed and developing countries, Technology Analysis and Strategic Management, 17(2), 2005, pp. 121-146.
7. J. Chataway and J. Smith, The international AIDS vaccine initiative (IAVI): Is it getting new science and technology to the world's neglected majority, World Development, 34(1), 2006, pp. 16-30.
8. See S. Chaturvedi, Exploring interlinkages between national and sectoral innovation systems for rapid technological catch-up: Case of Indian biopharmaceutical industry, Technology Analysis and Strategic Management, 19(5), 2007.
9. J. Tait, Systemic interactions in life science innovation, Technology Analysis and Strategic Management, 19(3), 2007, pp. 257-277.
10. C-P.Milne, Fixing the paradigm for biopharmaceutical R&D: Where to start?, Int. J. Biotechnology, 2008, in press.
11. Tait, op. cit., Ref. 6.
12. Ibid.
13. J. Mittra, The socio-political economy of pharmaceutical mergers: A case study of Sanofi and Aventis, Technology Analysis and Strategic Management, 18(5), 2006, pp. 473-496
14. and J. Mittra, Life science innovation and the restructuring of the pharmaceutical industry: Merger, acquisition and stratetic alliance behaviour of large firms, Technology Analysis and Strategic Management, 19(3), 2007, pp. 279-301.
15. Chaturvedi et al., op. cit., Ref. 1.
16. Thorsteinsdóttir et al., op. cit., Ref. 2.
17. Chaturvedi et al., op. cit., Ref. 1, p. 15. That article charts the impact of recent increases in R&D of Indian firms.
18. Kale & Little, op. cit., Ref. 1.
19. D. J. Bower & J. Sulej, The Indian challenge: The evolution of a successful new global strategy in the pharmaceutical industry, Technology Analysis and Strategic Management, 19(5), 2007.
20. Ibid.
21. Thorsteinsdóttir, op. cit., Ref. 2.
22. Kale & Little, op. cit., Ref. 1.
23. Bower & Sulej, op. cit., Ref. 15.
24. A. Sharma, Stem cell research in India: Emerging scenario and policy concerns,Asian Biotechnology and Development Review, 8(3), 2006, pp. 43-53.
25. Tait, op. cit., Ref. 6.
26. One exception is Novo Nordisk.
27. Chataway & Smith, op. cit., Ref. 4.
28. See J. Murphy (Ed.), The Governance of Sustainable Technology (London, Earthscan, 2007), for a number of examples of such attempts.
29. For more on the way in which PPPs operate, see J. Chataway, S. Brusoni, E. Cacciatori, R. Hanlin & L.Orsenigo, The international AIDS vaccine initiative (IAVI) in a changing landscape of vaccine development: A public private partnerships as knowledge broker and integrator, European Journal of Development Research, 19(1), 2007, pp. 100-117.
30. Chaturvedi et al., op. cit., Ref. 1.